Good day Katie
Thank you for bringing this article to the attention of forum members. [https://www.hifa.org/dgroups-rss/ehs-covid-182-impact-covid-19-cancer-se...
I concur with the need to harness the use of telemedicine as we work to revitalise oncology services. This also requires a shift of policy in some countries which did not have provisions for telemedicine in their legislation. In my opinion it will be critical to look at issues of data integrity and issues of confidentiality as we try to serve our clients in the best ways we can.
Regards,
Venus Mushininga
Program Manager, Non Communicable Diseases
Ministry of Health and Child Care
Fourth street/Central Avenue
P O BOX CY 1122
Causeway Harare
Phone +2634798554/60
Mobile +263783182249
Skype id : Venus Mushininga
HIFA profile: Venus Mushininga is a pharmacist with the Ministry of Health and Childcare in Zimbabwe. She is a founder and President of the Zimbabwe Society of Oncology Pharmacy and the Zimbabewan delegate to the European Society of Oncology Pharmacy. Professional interests: Oncology, Dissemination of information through to Health Professionals and the public, Research. She is co-coordinator of the HIFA working group on information for Prescribers and Users of Medicines.
Email: vmushininga@gmail.com
http://www.hifa.org/projects/prescribers-and-users-medicines
http://www.hifa.org/support/members/venus
Email: vmushininga AT gmail.com
